NCT07459621 Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking
| NCT ID | NCT07459621 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kaiser Permanente |
| Condition | Smoking Behaviors |
| Study Type | INTERVENTIONAL |
| Enrollment | 800 participants |
| Start Date | 2026-03-29 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 800 participants in total. It began in 2026-03-29 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to compare the effectiveness of two smoking cessation programs to determine which better helps people change their smoking behavior, the control or the experimental intervention? Both interventions include access to a mHealth app and other publicly available stop-smoking resources. The two app versions each include best practice advice and guidance for quitting smoking, but one includes additional content designed for people who aren't ready to quit smoking. The investigators hypothesize that people who receive the experimental intervention will be more likely to request additional stop-smoking resources offered through the intervention and report smoking abstinence after 6 months. The investigators also hypothesize people assigned to the experimental app will have better app engagement and be more likely to report positive changes in their smoking behavior and use of other evidence-based stop smoking treatments that are publicly available.
Eligibility Criteria
Inclusion Criteria: * 18 years of age and older * Current cigarette smoker who is ambivalent about smoking * Not actively using any treatment to quit smoking * Own and regularly use a smartphone * State willingness to install and use their assigned app * Willingness to receive study communications * Smoke at least half a pack a day * Meet geolocation requirements Exclusion Criteria: * A lifetime history of dementia or psychosis * Visual impairments that prevent viewing phone content and they lack adaptive devices * Report medical contra-indications for over-the-counter NRT use * Due to the potential for bias introduced by fraudulent participants, other exclusions will be applied to deter fraudulent enrollment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07459621 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Behaviors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07459621 currently recruiting?
Yes, NCT07459621 is actively recruiting participants. Contact the research team at jennifer.b.mcclure@kp.org for enrollment information.
Where is the NCT07459621 trial being conducted?
This trial is being conducted at Portland, United States.
Who is sponsoring the NCT07459621 clinical trial?
NCT07459621 is sponsored by Kaiser Permanente. The trial plans to enroll 800 participants.